|
|
||||||||
1 Multidisciplinary Research Group in Hypertension, Institut de Recherches Cliniques de Montréal, Montreal, Quebec H2W 1R7; and 2 Division of Cardiology, Mount Sinai Hospital, University Health Network, Toronto, Ontario, Canada M5G 2C4
| |
ABSTRACT |
|---|
|
|
|---|
We previously reported that the
left ventricular (LV) mass of Wistar-Kyoto (WKY)-derived hyperactive
(WKHA) rats was higher than that of WKY rats in the absence of a
difference in systolic blood pressure. To extend these earlier
observations, we conducted a series of functional and morphological
investigations on both strains. Analysis of tissue sections revealed
that the surface of ventricular tissue from WKHA rats was higher than
that of WKY rats, without any enlargement of the cavity area. Analysis
of isolated adult cells showed that cell width (as well as cell volume) of ventricular cardiomyocytes was significantly higher in WKHA than WKY
rats. However, LV of WKHA rats contained ~33% less cardiomyocytes than those from WKY rats. Mean intracellular free calcium concentration of cardiomyocytes was also higher in WKHA than WKY rats. Hemodynamic measurements revealed that the values of the maximum rates of pressure
change (dP/dt) were higher in LV from WKHA rats. However, these differences were reduced (
dP/dt) or abolished
(+dP/dt) when the values were normalized for both the number
and mean cross-sectional area of ventricular cardiomyocytes. Mean
levels of systolic and diastolic blood pressure (corresponding to the
24-h average of measurements obtained continuously in conscious
unrestrained animals using radiotelemetric implants) were not
different between strains. However, circadian rhythm was more evident
in WKY rats, because the difference between morning and night values of
systolic and diastolic blood pressure was greater (by 3 mmHg) in WKY
rats. Altogether, our data validate the use of WKHA rats as models of predominantly concentric LV hypertrophy developing in the absence of
increased mean levels of hemodynamic cardiac load and show that the
hypertrophy phenotype is more pronounced in isolated cardiomyocytes
than at the level of the whole ventricle.
cell width; intracellular free calcium concentration; left ventricular hypertrophy; cardiac morphology; cardiac function
| |
INTRODUCTION |
|---|
|
|
|---|
CARDIOVASCULAR DISEASES are the principal cause of mortality and morbidity in industrialized countries, and several studies have indicated that left ventricular (LV) hypertrophy (LVH) constitutes a powerful independent risk factor for cardiovascular mortality and morbidity (8, 22). Although LVH is commonly associated with hypertension, experimental evidence in both humans and animal models indicates that LVH may develop, at least in part, independently of blood pressure (10, 18, 20, 25, 27). It is therefore important to identify the appropriate models that will make it possible to study the factors that control LV mass independently of blood pressure.
Recently, Sehbi et al. (27) reported that the LV mass of Wistar-Kyoto (WKY) rats was greater than that of F344 rats and used crosses between the two strains to identify a locus on chromosome 3 that was linked to LV mass. These authors measured blood pressure in animals from both strains shortly after the surgical implantation of an arterial catheter and found that both strains were normotensive but that mean blood pressure was slightly higher in F344 rats (the strain with the lower LV mass) than in WKY rats. Likewise, we compared LV mass in WKY-derived hyperactive (WKHA) and WKY rats (23). WKHA are recombinant inbred rats derived from phenotypic selection and repeated inbreeding of the progeny of WKY/spontaneously hypertensive rat (SHR) crosses (19). Genetic tests have established that all alleles found in WKHA rats could be found in the parental WKY or SHR and that WKHA rats showed ~84% genetic relatedness compared with WKY rats (7). We found that the LV mass was higher in WKHA than WKY rats, although systolic blood pressure (as measured by tail plethysmography in conscious animals) was normal and similar in both strains (23). The interest of the latter model is increased by the fact that we (6) recently identified in WKHA/WKY crosses loci linked to LV mass independently of blood pressure. Altogether, these studies indicate that genes may increase LV mass even in the absence of high blood pressure.
In our previous studies, LVH of WKHA was characterized solely on the basis of the ratio of LV weight to body weight and the concentration of biochemical markers of hypertrophy. Furthermore, "spot" measurements of blood pressure may not be sufficient to appropriately evaluate the hemodynamic load of the heart to its full extent. To complete our previous investigations and characterize our animal model in further detail, we performed a systematic functional and morphological comparison of the characteristics of the LV and/or freshly isolated cardiomyocytes from WKHA and WKY rats. Moreover, blood pressure was measured in conscious and unrestrained animals of both strains by continuous monitoring of blood pressure using surgically implanted radiotelemetry devices, because this technique is the one that provides the most precise measurements of arterial blood pressure (4).
| |
METHODS |
|---|
|
|
|---|
Animals. All procedures on animals were approved by the Institut de Recherches Cliniques de Montréal (IRCM) Institutional Animal Care Committee and conducted according to guidelines issued by the Canadian Council on Animal Care. The nomenclature of the strains is in compliance with the recommendations of the International Rat Genetic Nomenclature Committee. The WKHA/Cfd rats originated from a colony maintained at the IRCM, as registered with the Institute of Laboratory Animal Resources. WKY/Cfd rats also originated from a colony maintained at the IRCM and were derived from WKY/Cr parents obtained from Charles River (St. Constant, Québec, Canada). All rats were maintained on a 12:12-h light-dark cycle, with lights being switched on at 6:00 AM.
Functional studies. To measure LV hemodynamics, 24-wk-old animals were intubated, mechanically ventilated, and instrumented with an A 2-Fr microtipped pressure transducer catheter (model SPR-407, Millar Instruments) as described previously (2). All variables were recorded on a Gould 2600S recorder. At the end of the dynamic investigations, the heart was stopped in diastole with a saturated potassium chloride solution, removed, and rinsed in saline solution. To construct passive pressure-volume curves, the LV was filled with saline using a catheter connected to a pump delivering at 12.7 µl/s. Pressure was recorded continuously with a calibrated pressure transducer. The procedure was performed twice for each heart.
Histology and morphology. After the pressure-volume curves were constructed, the LV of each diastole-arrested heart was filled with saline to a pressure of 15 mmHg, sealed, and fixed in its distended form in formalin. Two 8-µm-thick cross sections were obtained at 1-mm intervals midway between the base and the apex of the LV. For morphology, tissue sections from nine adult WKHA and nine WKY rats (the same as those used for functional studies) were stained with hematoxylin-eosin, photographed 1:1, digitized with a scanner, and stored as electronic files. Each digital image was then analyzed with Northern Eclipse version 6.0 software (Empix Imaging; Missisauga, Ontario, Canada) to calculate the outer perimeter of the LV as well as the surface occupied by the LV parenchyma and the LV cavity. Additional sections were stained by Sirius red to visualize collagen fibers (see Collagen quantification).
Isolated cardiomyocytes. Cardiomyocytes were isolated from five WKHA and five WKY rats (12 wk of age). Each time cells were prepared, one WKHA and one WKY rat were used concomitantly. The hearts were rapidly removed from anesthetized animals previously injected intraperitoneally with 500 units heparin sulfate, and Ca2+-tolerant cardiomyocytes were isolated by the Langendorff method (cardiac retrograde aortic perfusion) similar to that described previously (30). Cardiocytes were separated from noncardiomyocytes by sedimentation on a solution of a 6% bovine serum albumin in medium 199. For morphological studies, isolated cardiomyocytes were fixed for 30 min in 0.08 M phosphate buffer containing 1.5% glutaraldehyde, lightly centrifuged, washed with 0.15 M phosphate buffer, and then maintained in the same buffer at 4°C until analyzed. Both solutions have been shown to preserve the volume of fixed cells compared with unfixed ones (14). Part of these cells were further fixed in osmium tetroxide, lightly centrifuged in microtubes, dehydrated, and Epon embedded. One-micrometer-thick sections were cut and counterstained with toluidine blue.
For intracellular Ca2+ measurements, freshly isolated cells were first allowed to settle in culture dishes for 90 min in culture medium containing 10% fetal bovine serum, switched to serum-free medium, and then finally maintained for another 18 h in a humidified incubator (5% CO2-95% air) at 37°C (see Intracellular calcium measurements).Intracellular calcium measurements. Intracellular free Ca2+ concentration ([Ca2+]i) was determined with the use of the fluorescent probe fura 2-AM, as described previously (30, 31). Briefly, cardiomyocytes were loaded with 4 µM fura 2-AM (dissolved in DMSO with 0.02% pluronic F-12) and incubated for 30 min at 37°C in a humidified incubator with 95% air-5% CO2. Cells were then washed three times with modified Hanks' buffer. Fluorescence was determined with an Axiovert 135 inverted microscope and Attofluor digital fluorescence system (Zeiss) using dual excitatory wavelengths of 343 and 380 nm and a single emission wavelength of 520 nm. Both in situ and in vitro calibrations were made according to our previously described methods (31). [Ca2+]i was determined with the equation of Grynkiewicz et al. (17).
Electron microscopy. Four male WKHA and four male WKY rats (12 wk of age) were used for tissue embedding. After anesthesia, a cannula was placed in the abdominal aorta. The hearts were then arrested in diastole by injection of 1 ml of 2 M KCl into the right ventricle, the right atrium was incised, and the hearts were retrogradely perfused with a heparinized solution of 0.15 M phosphate buffer at a controlled pressure of ±80 mmHg. After 5 min of perfusion, the perfusate was switched to a solution of 1.5% glutaraldehyde in 0.08 M phosphate buffer for 15 min. The hearts were then excised, and tissue blocks were collected from both the endocardial and epicardial side of the LV (either free wall or septum) and Epon embedded. Ultrathin sections were counterstained with lead and uranyl acetate, collected on grids, and examined with a Jeol 1200 transmission electron microscope. Each grid was examined at both 4 and 12 K magnifications. Several photographs were taken from each grid, and each negative was scanned and saved as an electronic file for further analysis with Adobe Photoshop 5.0 software. The calculation of the cardiomyocyte fractional volume (CFV) was performed in two steps. First, the percentage of surface occupied by myocardial tissue (excluding vascular and extravascular spaces) was performed on the files of pictures taken at 4 K magnification using Adobe Photoshop 5.0 to calculate the relative surface of the two compartments. In a second step, the files of higher magnification (12 K) pictures were analyzed to calculate the percentage of surface occupied by cardiomyocytes (excluding extracellular spaces and noncardiomyocytes). The final CFV was then calculated by multiplying one fraction by the other. For each strain, nine additional animals (12 wk of age) were killed for the determination of the LV weight and calculation of the number of cardiomyocytes per LV. The latter calculations were performed as described previously (15) using the equation (CFV/VTV)/ ICV, where CFV was calculated as described above, VTV is the ventricular tissue volume (calculated by dividing the LV mass by 1.06, which corresponds to the tissue-specific gravity of cardiac tissue), and ICV is the isolated cardiomyocyte volume (calculated as described in Quantitative videomicroscopy).
Quantitative videomicroscopy. Isolated and fixed cardiomyocytes (prepared from five animals from each strain) were allowed to settle in petri dishes containing 0.15 M phosphate buffer and examined with a Zeiss Axiovert microscope connected to a videocamera that allowed capture of the images as electronic files. With the use of Northern Eclipse version 6.0 software, ~100 cells (±5) from each animal were analyzed for determination of cell length and cell surface. On the basis of these measurements, cell width was calculated as the surface-to-length ratio.
For validation of cross-sectional measurements, semithin sections of Epon-embedded cells were also examined at high magnification. We performed measurements on undamaged cardiomyocytes in which cross-sectioned sarcomeres were clearly visible. We calculated that the thickness of the sarcomeres in cross-sectioned cells was 1.89 ± 0.14 (SD) µm for WKHA cells and 1.83 ± 0.16 (SD) µm for WKY cells. In both cases, the maximal deviation from the true sarcomere thickness did not exceed 15%, thus ensuring that the measurements were representative of truly cross-sectioned cardiomyocytes (15). On each ellipsoid cardiomyocyte profile, we used Northern Eclipse version 6.0 software to measure the major diameter, minor diameter, and surface area.Collagen quantification. The abundance of collagen fibers was quantified using two different methods. First, sections from seven WKHA and seven WKY adult rats (which had been used previously for the functional studies) were stained with Sirius red and examined under epipolarization with a Zeiss Axiovert microscope using a ×10 objective. For each ventricular section, 10 separate fields displaying well-stained interstitial fibers (and no accumulation of perivascular collagen) were selected. The percentage of the field containing stained fibers was calculated using Northern Eclipse version 6.0 software. In a separate experiment, collagen was measured biochemically in extracts from the LV of five WKHA and five WKY adult rats using a previously described method (5). Briefly, frozen ventricular tissue was pulverized under liquid nitrogen, 100 mg of tissue powder was dissolved in a tube containing 500 µl of concentrated HCl and 500 µl of water, and the tubes were incubated at 108°C for 16 h. After the tubes cooled, 4 ml of 1 N NaOH were added, the tubes were centrifuged, and aliquots of supernatant were used for the assay. Standards were prepared from a stock solution of 1 mg/ml trans-4-hydroxy-L-proline in 10 mM HCl and ranged from 1 to 12 µg/ml. Hydrolysis was as described previously. For the assay, 50-µl aliquots of sample were placed in wells of a 96-well plate. Oxidizing solution (100 µl) was then added to each well and allowed to incubate for 5 min. Ehrlich's reagent (100 µl) was then added to each well, and the plate was incubated for another 45 min at 60°C. Absorbance was then read at 570 nm using a microplate optical density reader.
Radiotelemetry measurement of blood pressure. Systolic and diastolic blood pressure were continuously and chronically monitored by radiotelemetry as previously described (4, 29). The telemetric transmitters (Datasciences International; St. Paul, MN) were implanted into the abdominal cavity of rats (with the catheter inserted into the distal portion of the descending aorta) at 10 wk of age. After a 2-wk recovery period, averages of 10-s samples obtained every 5 min were used to monitor systolic and diastolic pressures in each rat. Night blood pressure values were defined as the mean of the values recorded between 6 PM and 6 AM. Morning blood pressure values were defined as the mean of the values recorded between 6 AM and 12 PM. Circadian blood pressure differences were defined as the differences between night and morning values (defined as described above).
| |
RESULTS |
|---|
|
|
|---|
The morphological characteristics of the LV from 24-wk-old WKHA
and WKY rats are summarized in Table 1.
LV mass was assessed by calculating the ratio of the LV weight to whole
body weight. There was an 11.6% increase of the LV weight-to-body
weight ratio of WKHA rats compared with WKY rats (P < 0.007). Analysis of tissue sections prepared from the same hearts
revealed that the surface of the ventricular parenchyma was increased
in WKHA rats compared with WKY rats (P < 0.016),
whereas the outer perimeter of the LV was similar in both strains.
There was also a tendency toward a smaller cavity area in WKHA rats
compared with WKY rats, although the difference did not reach
statistical significance. Collagen abundance was quantified in two
different ways. Quantification of Sirius red-stained fibers provided
primarily an estimate of the abundance of interstitial collagen,
because care was taken not to include perivascular collagen. It
revealed that the amount of collagen fibers was ~15% lower in WKHA
than WKY rats, the significance of that difference being questionable
(P = 0.045). Biochemical measurements of the
hydroxyproline content in digested samples yielded an estimate of total
collagen and detected no significance difference between WKHA and WKY
rats.
|
Analysis of cell size was performed on isolated cardiomyocytes, because
it has been argued that this method yielded much more reliable data
than analysis of tissue sections (12). A representative picture is shown in Fig. 1. Analysis of
the cells revealed a 34.8% increase in mean width (P < 0.0001) and a 42% increase of the width-to-length ratio
(P < 0.0001), whereas no significant difference was
found in cell length (Table 2). To
calculate cell volume, we used a technique that allows one to calculate
the cross-sectional surface from the cell width. Indeed, it has been
reported that the cross section of a cardiomyocyte can be approximated
to an ellipse shape and that its surface can be calculated on the basis of the formula
AB/4, where A and B
correspond to the major and minor diameter of the ellipse, respectively
(13). To verify that the B-to-A
ratio was similar in both strains, we first used semithin sections of
Epon-embedded cells and performed measurements at high magnification on
undamaged cardiomyocytes where cross-sectioned sarcomeres were clearly
visible. To ensure that the profiles originated from truly
cross-sectioned cardiomyocytes, we measured the thickness of sarcomeres
within these cells and obtained values of 1.89 ± 0.14 and
1.83 ± 0.16 (SD) µm for WKHA and WKY cells,
respectively. These values indicate that, for each strain, the
maximal deviation from true sarcomere thickness never exceeded 15%,
thus ensuring that the measurements were representative of truly
cross-sectioned cardiomyocytes (15). We then calculated
that the B-to-A ratio was 0.59 ± 0.07 and
0.59 ± 0.11 (SE) in cardiomyocytes from WKHA and WKY rats,
respectively. When using this ratio and the equation described above,
we observed that the values of calculated cross-sectional area (CSA)
were 96.2 ± 20.6% (SD, n = 20) of the values of
directly measured CSA for WKHA rats. Likewise, the values of calculated CSA were 95.6 ± 18.7% (SD, n = 24) of the values
of directly measured CSA for WKHA rats. Thus, provided that a
sufficiently high number of cells were measured, values calculated on
the basis of cell width were comparable with that of directly measured
CSA. When these calculations were applied to the greater number of
cells (>100 per animal) examined in the petri dishes, we calculated that CSA values and volume of cardiomyocytes from WKHA rats were 74%
(P < 0.0001) and 54% (P < 0.0001)
higher than corresponding values from cardiomyocytes from WKY rats.
|
|
Analysis by electron microscopy of sections from hearts fixed by controlled perfusion allowed us to calculate that CFV was 70.1% for WKHA rats and 73.7% for WKY rats. With the use of these values, it was possible to calculate that LV from WKHA rats contained ~16.9 million cardiomyocytes, which corresponded to 33.6% more cells than the 11.2 million cardiomyocytes in LV from WKY rats. Finally, experiments with cells loaded with fura 2-AM indicated that basal [Ca2+]i in isolated cardiomyocytes was ~54% higher in cells from WKHA rats than in cells from WKY rats (P < 0.0001).
Functional evaluations were performed on ten 24-wk-old animals of each
strain to measure the maximum rate of positive and negative pressure
change (+dP/dt and
dP/dt, respectively; Table 3). In WKHA rats, the values of
LV +dP/dt (P = 0.03) and LV
dP/dt (P = 0.004) were significantly
higher than those of WKY rats. Of note, the differences became more
significant when the values were normalized for the numbers of
cardiomyocytes in the LV from either WKHA or WKY rats. However, the
differences were either abolished (for +dP/dt) or greatly
reduced (
dP/dt) when the normalized values were further
divided by the average CSA. There was no significant difference in the
LV end-diastolic pressure (LVEDP). Examination of the passive diastolic
properties of the ventricles of WKHA and WKY rats by comparison of the
pressure-volume curves did not detect differences in the properties of
ventricles from each strain (Fig. 2).
|
|
Figure 3 shows a graphic representation
of the mean values of systolic and diastolic blood pressures as
recorded by telemetry for four continuous nyctemers in five 12-wk-old
animals from each strain. When averaged over 4 days, the mean values of
systolic and diastolic blood pressure (130.2 ± 4.1 and 92.4 ± 0.9 mmHg for WKHA rats compared with 129.5 ± 3.5 and 90.5 ± 4.9 mmHg for WKY rats, respectively) were not significantly
different. However, examination of the profile of blood pressure
variations revealed that circadian differences were more apparent in
WKY than WKHA rats. Accordingly, WKHA rats exhibited a night-morning
circadian difference of systolic and diastolic pressure that amounted
to ~3.5 mmHg. That value was significantly lower (P < 0.05) than the night-morning circadian difference of systolic and
diastolic pressure of 6.5 mmHg observed in WKY rats.
|
| |
DISCUSSION |
|---|
|
|
|---|
The main finding of our study is that many features of LVH exist in WKHA rats despite mean levels of arterial blood pressure that are not different from WKY rats. From these features, it is also possible to characterize the type of hypertrophy present in WKHA hearts. Classically, LVH has been categorized into two basic types (16): concentric hypertrophy (where wall thickness increases without chamber enlargement) and eccentric hypertrophy (where chamber volume enlarges without a relative increase in wall thickness). According to these criteria, analysis of cross-sectional tissue sections indicated that LVH in WKHA rats is predominantly of the concentric type. Furthermore, our analysis of isolated cells revealed that the width of cardiomyocytes from WKHA rats was larger than that from WKY rats. In addition to confirming the role of cardiomyocytes in the general enlargement of the ventricles, the fact that the enlargement was caused by the larger width of cardiomyocytes (in contrast to absence of difference in length) is also consistent with what is expected when concentric hypertrophy is present (11, 16). Interestingly, despite the LVH in WKHA rats, there was no increased fibrosis, as indicated by the quantification of collagen and by the absence of shift of the passive pressure-volume relationship of the WKHA LV compared with that of the WKY LV.
Another important finding was that alterations were much more important at the level of isolated cardiomyocytes than at the macroscopic level (as determined by calculation of the LV weight-to-body weight ratio). Indeed, we calculated that the volume of cardiomyocytes was increased by ~54% in WKHA rats compared with WKY rats. In light of such large differences at the cellular level, one must postulate the existence of other factors to explain why the LV mass was only 10% larger. Interestingly, we also calculated that the total number of cardiomyocytes was ~33% lower in LV from WKHA rats than the LV from WKY rats, a fact that might explain in part why the difference in LV mass between WKHA and WKY rats was less pronounced than the differences in volume of isolated cardiomyocytes.
Functionally, we observed that the dP/dt values
obtained in WKHA hearts were significantly higher than those in WKY
hearts, similar to what has been previously reported in papillary
muscles from SHR compared with WKY rats (3).
However, the differences became more significant when the values were
normalized for the numbers of cardiomyocytes in LV from either WKHA and
WKY rats but were then either abolished (+dP/dt) or greatly
reduced (
dP/dt) when the values normalized for cell number
were further divided by average CSA. This most likely indicates that
changes in contractility observed at the level of whole ventricles most
likely reflect changes in the number and size of cardiomyocytes and
presumably by changes in the number of contractile units in parallel
(3). Another important parameter is that of diastolic
function, which has previously been shown to be impaired early in the
course of LVH (9). However, comparison of the passive
diastolic pressure-volume curves revealed no difference in compliance
of the LV of both strains. In vivo, the LVEDP was slightly more
elevated at 24 wk of age in WKHA than WKY rats, but the difference was
not significant. Finally, we observed that basal
[Ca2+]i was 54% higher in isolated
cardiomyocytes of WKHA rats than in those of WKY rats, in agreement
with other studies (21, 28) showing that that mean basal
[Ca2+]i and Ca2+ handling were
affected in several models of experimental and/or genetic LVH.
Taken together, our observations concur to indicate that LVH in WKHA rats is predominantly concentric in nature and that the cardiomyocytes from WKHA LV are both increased in size and reduced in number compared with cardiomyocytes from WKY LV. In light of these findings, it is important to know whether LV from both strains are exposed to the same level of hemodynamic load. To have the most accurate measurements of blood pressure, we recorded blood pressure continuously in unrestrained conscious animals using radiotelemetric implants (4). Mean levels of systolic and diastolic blood pressure (as averaged over 4 days) were identical in both strains. However, the plot of mean levels of blood pressure over time revealed that there might be more subtle differences, because circadian variation was more obvious in WKY than WKHA rats. Calculation of the differences of blood pressure between morning and night values revealed that systolic and diastolic morning pressure decreased to lower levels in WKY than in WKHA rats. This observation raises the question as to whether differences in circadian variability may have an impact (beyond that of mean levels of blood pressure) on LV mass. In humans, differences in circadian variability have been associated with an increase in cardiovascular mortality (24). More specifically, some studies (26, 32) have found that a blunting of circadian differences was associated with an increase in LV mass. However, such an association has not been found consistently across studies (1). Furthermore, circadian differences were much more pronounced in humans than rats, because the circadian differences of blood pressure ranged from 15 to 20 mmHg in "dippers" and from 3 to 6 mmHg in "nondippers" (24, 32). The difference in circadian rhythm between WKHA and WKY rats was significant but amounted to only 3 mmHg in blood pressure. It remains to be determined whether such a small difference may have any impact on LV mass. Nonetheless, given what has been reported in humans, the association between higher LV mass and blunted circadian rhythm in WKHA rats is intriguing and constitutes the first instance where it has been reported in an animal model.
In summary, our data validate the use of WKHA rats as models of a predominantly concentric LVH developing in the absence of significant changes in mean levels of hemodynamic cardiac load and show that the hypertrophy phenotype is more pronounced in isolated cardiomyocytes than at the level of the whole ventricle. These data should prove particularly useful when trying to elucidate which features of LVH are linked to particular genes or loci in the course of forthcoming linkage studies performed with crosses between these two strains.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Robert Clément for help with the hemodynamic studies.
| |
FOOTNOTES |
|---|
This work was supported by Canadian Institutes in Health Research (CIHR) Grants MOP-14086 and MOP-36449, by a CIHR group grant to the Multidisciplinary Research Group in Hypertension, and by a Fondation des Maladies du Coeur du Québec grant (to C. F. Deschepper).
Address for reprint requests and other correspondence: C. Deschepper, Laboratory of Experimental Cardiovascular Biology, Clinical Research Institute of Montreal, 110 Pine Ave. W., Montreal, Quebec, Canada H2W 1R7 (E-mail: deschec{at}ircm.qc.ca).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published September 27, 2001; 10.1152/ajpheart.00672.2001
Received 30 July 2001; accepted in final form 19 September 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Belsha, CW,
Wells TG,
McNiece KL,
Seib PM,
Plummer JK,
and
Berry PL.
Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension.
Am J Hypertens
11:
410-417,
1998.
2.
Bélichard, P,
Savard P,
Cardinal R,
Nadeau R,
Gosselin H,
Paradis P,
and
Rouleau JL.
Markedly different effects on ventricular remodelling result in a decrease in inducibility of ventricular arrhythmias.
J Am Coll Cardiol
23:
505-513,
1994.
3.
Bing, OHL,
Wiegner AW,
Brooks WW,
Fishbein MC,
and
Pfeffer JM.
Papillary muscle structure-function relations in the aging spontaneously hypertensive rat.
Clin Exp Hypertens
10:
37-58,
1988.
4.
Brockway, BP,
Mills PA,
and
Azar SH.
A new method for continuous chronic measurement and recording of blood pressure, heart rate and activity in the rat via radio-telemetry.
Clin Exp Hypertens
13:
885-895,
1991.
5.
Brown, S,
Worsfold M,
and
Sharp C.
Microplate assay for the measurement of hydroxyproline in acid-hydrolyzed tissue samples.
Biotechniques
30:
42-48,
2001.
6.
Deschepper, CF,
Masciotra S,
Zahabi A,
Boutin-Ganache I,
Picard S,
and
Reudelhuber T.
Functional alterations of the Nppa promoter are linked to cardiac ventricular hypertrophy in WKY/WKHA rat crosses.
Circ Res
88:
222-227,
2001.
7.
Deschepper, CF,
Prescott G,
Hendley ED,
and
Reudelhuber TL.
Genetic characterization of novel strains of rats derived from crosses between Wistar-Kyoto and spontaneously hypertensive rats and comparisons with their parental strains.
Lab Anim Sci
47:
638-646,
1997.
8.
Devereux, RB,
de Simone G,
Ganau A,
and
Roman MJ.
Left ventricular hypertrophy and geometric remodeling in hypertension: stimuli, functional consequences and prognostic implications.
J Hypertens
12 Suppl10:
S117-S127,
1994.
9.
Douglas, PS,
Berko B,
Lesh M,
and
Reichek N.
Alterations in diastolic function in response to progressive left ventricular hypertrophy.
J Am Coll Cardiol
13:
461-467,
2000.
10.
Ganau, A,
Devereux RB,
Pickering TG,
Roman MJ,
Schnall PL,
Santucci S,
Spitzer MC,
and
Laragh JH.
Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension.
Circulation
81:
25-36,
1990.
11.
Gerdes, AM.
The use of isolated myocytes to evaluate myocardial remodeling.
Trends Cardiovasc Med
2:
152-155,
1992.
12.
Gerdes, AM,
and
Capasso JM.
Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failure.
J Mol Cell Cardiol
27:
849-856,
1995.
13.
Gerdes, AM,
Kellerman SE,
Malec KB,
and
Schocken DD.
Transverse shape characteristics of cardiac myocytes from rats and humans.
Cardioscience
5:
31-36,
1994.
14.
Gerdes, AM,
Kriseman J,
and
Bishop SP.
Morphometric study of cardiac muscle. The problem of tissue shrinkage.
Lab Invest
46:
271-274,
2001.
15.
Gerdes, AM,
Moore JA,
Hines JM,
Kirkland PA,
and
Bishop SP.
Regional differences in myocyte size in normal rat heart.
Anat Rec
215:
420-426,
1986.
16.
Grossman, W,
Jones D,
and
McLaurin LP.
Wall stress and patterns of hypertrophy in the human left ventricle.
J Clin Invest
56:
56-64,
1975.
17.
Grynkiewicz, G,
Poenie M,
and
Tsien TY.
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
J Biol Chem
260:
3440-3450,
1985.
18.
Hamet, P,
Kaiser MA,
Sun Y,
Pagé V,
Vincent M,
Kren V,
Pravenec M,
Kunes J,
Tremblay J,
and
Samani NJ.
HSP27 locus cosegregates with left ventricular mass independently of blood pressure.
Hypertension
28:
1112-1117,
1996.
19.
Hendley, ED,
and
Ohlsson WG.
Two new inbred rat strains derived from SHR: WKHA, hyperactive, and WKHT, hypertensive, rats.
Am J Physiol Heart Circ Physiol
261:
H583-H589,
1991.
20.
Innes, BA,
McLaughlin MG,
Kapuscinski MK,
Jacob HJ,
and
Harrap SB.
Independent genetic susceptibility to cardiac hypertrophy in inherited hypertension.
Hypertension
31:
741-746,
1998.
21.
Kawaguchi, H,
Sano H,
Iizuka K,
Okada H,
Kudo T,
Kageyama K,
Muramoto S,
Murakami T,
Okamoto H,
Mochizuki N,
and
Kitabatake A.
Phosphatidylinositol metabolism in hypertrophic rat heart.
Circ Res
72:
966-972,
1993.
22.
Levy, D,
Garrison RJ,
Savage DD,
Kannel WB,
and
Castelli WP.
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study.
N Engl J Med
322:
1561-1566,
1990.
23.
Masciotra, S,
Picard S,
and
Deschepper CF.
Cosegregation analysis in genetic crosses suggests a protective role for atrial natriuretic factor against ventricular hypertrophy.
Circ Res
84:
1453-1458,
1999.
24.
Ohkubo, T,
Imai Y,
Tsuji I,
Nagai K,
Watanabe N,
Minami N,
Kato J,
Kikuchi N,
Nishiyama A,
Aihara A,
Sekino M,
Satoh H,
and
Hisamachi S.
Relation between nocturnal decline in blood pressure and mortality.
Am J Hypertens
10:
1201-1207,
1997.
25.
Pravenec, M,
Gauguier D,
Schott J-J,
Buard J,
Kren V,
Bila V,
Szpirer C,
Szpirer J,
Wang J-M,
Huang H,
St Lezin E,
Spence MA,
Flodman P,
Printz M,
Lathrop GM,
Vergnaud G,
and
Kurtz TW.
Mapping of quantitative trait loci for blood pressure and cardiac mass in the rat by genome scanning of recombinant inbred strains.
J Clin Invest
96:
1973-1978,
1995.
26.
Rizzoni, D,
Muiesan ML,
Montani G,
Zulli R,
Calebich S,
and
Agabiti-Rosei E.
Relationship between initial cardiovascular structural changes and daytime and nightime blood pressure monitoring.
Am J Hypertens
5:
180-186,
1992.
27.
Sebkhi, A,
Zhao L,
Lu L,
Haley CS,
Nunez DJR,
and
Wilkins MR.
Genetic determination of cardiac mass in normotensive rats. Results from an F344×WKY cross.
Hypertension
33:
949-953,
1999.
28.
Shorofsky, SR,
Aggarwal R,
Corretti M,
Baffa JM,
Strum JM,
Al-Sheikhan BA,
Kobayashi Y,
Jones LR,
Wier WG,
and
Balke CW.
Cellular mechanisms of altered contractility in the hypertrophied heart.
Circ Res
84:
424-434,
1999.
29.
Sventek, P,
Li J-S,
Grove KL,
Deschepper CF,
and
Schiffrin EL.
Vascular structure and expression of endothelin-1 gene in malignant hypertension induced by L-NAME treatment in spontaneously hypertensive rats.
Hypertension
27:
49-55,
1996.
30.
Touyz, RM,
Fareh J,
Thibault G,
and
Schiffrin EL.
Intracellular Ca2+ modulation by angiotensin II and endothelin-1 in cardiomyocytes and fibroblasts from hypertrophied hearts of spontaneously hypertensive rats.
Hypertension
28:
797-805,
1996.
31.
Touyz, RM,
Fareh J,
Thibault G,
Tolloczko B,
Larivière R,
and
Schiffrin EL.
Modulation of Ca2+ transients in neonatal and adult rat cardiomyocytes by angiotensin II and endothelin-1.
Am J Physiol Heart Circ Physiol
270:
H857-H868,
1996.
32.
Verdecchia, P,
Schillaci G,
Guerrieri M,
Gatteschi C,
Benemio G,
Boldrini F,
and
Porcellati C.
Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension.
Circulation
81:
528-536,
1990.
This article has been cited by other articles:
![]() |
B. Llamas, S. Belanger, S. Picard, and C. F. Deschepper Cardiac mass and cardiomyocyte size are governed by different genetic loci on either autosomes or chromosome Y in recombinant inbred mice Physiol Genomics, October 19, 2007; 31(2): 176 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Palmer, Z. Chen, R. R. Lachapelle, E. D. Hendley, and M. M. LeWinter Cardiomyocyte function associated with hyperactivity and/or hypertension in genetic models of LV hypertrophy Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H463 - H473. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Souzeau, S. Belanger, S. Picard, and C. F. Deschepper Dietary isoflavones during pregnancy and lactation provide cardioprotection to offspring rats in adulthood Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H715 - H721. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Aiello, M. C. Villa-Abrille, E. M. Escudero, E. L. Portiansky, N. G. Perez, M. C. Camilion de Hurtado, and H. E. Cingolani Myocardial hypertrophy of normotensive Wistar-Kyoto rats Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1229 - H1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Boutin-Ganache, S. Picard, and C. F. Deschepper Distinct gene-sex interactions regulate adult rat cardiomyocyte width and length independently Physiol Genomics, December 26, 2002; 12(1): 61 - 67. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |